Ma D - Search Results

1

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.

Jin X, Jiang YZ, Chen S, Yu KD, Ma D, Sun W, Shao ZM, Di GH. Jin X, et al. Among authors: ma d. BMC Cancer. 2016 Aug 5;16:606. doi: 10.1186/s12885-016-2652-z. BMC Cancer. 2016. PMID: 27495967 Free PMC article.

2

Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.

Sun W, Jiang YZ, Liu YR, Ma D, Shao ZM. Sun W, et al. Among authors: ma d. Oncotarget. 2016 Apr 12;7(15):20496-506. doi: 10.18632/oncotarget.7975. Oncotarget. 2016. PMID: 26967253 Free PMC article.

3

Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.

Ma D, Jiang YZ, Liu XY, Liu YR, Shao ZM. Ma D, et al. Breast Cancer Res Treat. 2017 Feb;162(1):39-48. doi: 10.1007/s10549-017-4113-z. Epub 2017 Jan 16. Breast Cancer Res Treat. 2017. PMID: 28093659

4

Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.

Yang HY, Ma D, Liu YR, Hu X, Zhang J, Wang ZH, Di GH, Hu XC, Shao ZM. Yang HY, et al. Among authors: ma d. Sci Rep. 2017 Apr 25;7(1):1134. doi: 10.1038/s41598-017-00663-1. Sci Rep. 2017. PMID: 28442763 Free PMC article.

5

Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status.

Xiao Y, Ma D, Ruan M, Zhao S, Liu XY, Jiang YZ, Shao ZM. Xiao Y, et al. Among authors: ma d. Sci Rep. 2017 Sep 4;7(1):10380. doi: 10.1038/s41598-017-10789-x. Sci Rep. 2017. PMID: 28871133 Free PMC article.

6

Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.

Zhao S, Ma D, Xiao Y, Jiang YZ, Shao ZM. Zhao S, et al. Among authors: ma d. Eur J Surg Oncol. 2018 Apr;44(4):420-428. doi: 10.1016/j.ejso.2017.11.027. Epub 2018 Jan 9. Eur J Surg Oncol. 2018. PMID: 29429597

7

The effect of delayed adjuvant chemotherapy on relapse of triple-negative breast cancer.

Li S, Ma D, Shi HH, Yu KD, Zhang Q. Li S, et al. Among authors: ma d. J Thorac Dis. 2018 May;10(5):2837-2841. doi: 10.21037/jtd.2018.04.94. J Thorac Dis. 2018. PMID: 29997947 Free PMC article.

8

Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.

Yang HY, Ma D, Liu YR, Hu X, Zhang J, Wang ZH, Di GH, Hu XC, Shao ZM. Yang HY, et al. Among authors: ma d. Sci Rep. 2018 Oct 12;8(1):15333. doi: 10.1038/s41598-018-32881-6. Sci Rep. 2018. PMID: 30310090 Free PMC article.

9

Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study.

Ye FG, Xia C, Ma D, Lin PY, Hu X, Shao ZM. Ye FG, et al. Among authors: ma d. BMC Cancer. 2018 Nov 8;18(1):1085. doi: 10.1186/s12885-018-4982-5. BMC Cancer. 2018. PMID: 30409127 Free PMC article.

10

Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.

Liu XY, Ma D, Xu XE, Jin X, Yu KD, Jiang YZ, Shao ZM. Liu XY, et al. Among authors: ma d. Theranostics. 2018 Dec 8;8(22):6386-6399. doi: 10.7150/thno.29164. eCollection 2018. Theranostics. 2018. PMID: 30613307 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,769 results

Search Page

Filters